Verification evidence is still being completed.
Saidė Genomics
Vilnius, Lithuania
- Verified lead
- Arūnas Leipus
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Director
- 2026 technical specialization
- Molecular Diagnostics, NIPT, Sequencing Services, Pharmacogenomics, and Cancer Testing
- Review cycle
- May 2026
- Full address
- Račių g. 1, LT-03154 Vilnius, Lithuania
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- State-register company record confirming the current published director for UAB Saidė.
- Editorial note
- Saidė Genomics is published as a Lithuania genomics node using a state-register director record for UAB Saidė together with official site evidence for the active Vilnius laboratory and sequencing-service footprint.
Molecular Diagnostics, NIPT, Sequencing Services, Pharmacogenomics, and Cancer Testing
ISO 15189:2023 laboratory workflow reference, EMQN top-score NIPT quality assessment, State-register medical laboratory activity classification
Saidė Genomics is published as a Lithuania genomics node using a state-register director record for UAB Saidė together with official site evidence for the active Vilnius laboratory and sequencing-service footprint.
Saidė Genomics runs non-invasive prenatal testing, sequencing services, and pharmacogenomic and cancer testing in Vilnius, Lithuania.
- Lead
- Arūnas Leipus (verified ↗)
- Address
- Račių g. 1, LT-03154 Vilnius, Lithuania (source ↗)
- Compliance
- ISO 15189:2023 laboratory workflow reference
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Clinical genomics and sequencing platform
- Capabilities
- Non-Invasive Prenatal Testing · Sequencing Services · Pharmacogenomic and Cancer Testing
- Founded
- 2020
- Headcount
- 1-10
Arūnas Leipus
Director
Official Saidė Genomics contact page listing the Račių g. 1 operating laboratory address in Vilnius.
Open sourceClinical genomics and sequencing platform
Vilnius, Lithuania. Molecular Diagnostics, NIPT, Sequencing Services, Pharmacogenomics, and Cancer Testing. Review completed on 21 Mar 2026.
Lithuanian state registers and laboratory-quality oversight for medical testing workflows
ISO 15189:2023 laboratory workflow reference, EMQN top-score NIPT quality assessment, State-register medical laboratory activity classification
Molecular Diagnostics, NIPT, Sequencing Services, Pharmacogenomics, and Cancer Testing
Saidė Genomics is published as a Lithuania genomics node using a state-register director record for UAB Saidė together with official site evidence for the active Vilnius laboratory and sequencing-service footprint.
Saidė Genomics is published as a Lithuania genomics node using a state-register director record for UAB Saidė together with official site evidence for the active Vilnius laboratory and sequencing-service footprint.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Saidė Genomics located?
- Saidė Genomics operates from Račių g. 1, LT-03154 Vilnius, Lithuania, Vilnius, Lithuania.
- Who runs Saidė Genomics?
- Saidė Genomics is led by Arūnas Leipus, Director. Verified 21 Mar 2026.
- What certifications does Saidė Genomics hold?
- Saidė Genomics is documented under ISO 15189:2023 laboratory workflow reference.
- What does Saidė Genomics do?
- Saidė Genomics runs non-invasive prenatal testing, sequencing services, and pharmacogenomic and cancer testing in Vilnius, Lithuania. Core capabilities: Non-Invasive Prenatal Testing, Sequencing Services, Pharmacogenomic and Cancer Testing.
Related technical briefs
Briefs that name Vilnius as a covered market or city.
